Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2012Transplant InternationalOpen Access

Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMartin‐Walter WelkerGoethe University FrankfurtWBWolf O. BechsteinGoethe University Frankfurt
Stefan Zeuzem
Stefan ZeuzemUniversité Claude Bernard Lyon 1

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Welker et al. (2012) studied this question.

synapsesocial.com/papers/6a975e96197de90645e32985https://doi.org/10.1111/j.1432-2277.2012.01562.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience2006 · 60 citations
  2. 2Global cancer statistics2011 · 55,020 citations
  3. 3Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma2009 · 43 citations
  4. 4Discovery and development of sorafenib: a multikinase inhibitor for treating cancer2006 · 1,846 citations
  5. 5Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma2010 · 133 citations